Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Aquestive Works with FDA to Resolve Hurdles for its New Sublingual Epinephrine Candidate

Hope on the Horizon: Ten Food Allergy Research Breakthroughs in 2025

Very Low-Dose Multi-Nut OIT Promising for Children with Multiple Food Allergies

DBV to Submit FDA Application After Viaskin Peanut Patch Achieves Goals in Phase 3 Trial

Mabylon Begins Human Clinical Trials of New Peanut Allergy Treatment

Microneedle Patch to Treat Peanut Allergy Receives Clinical Trial Grant

FDA Delays Approval of neffy™ Intranasal Epinephrine Until September

Viatris, Seller of EpiPen®, Petitions FDA to Delay Approval of neffy™...

Alladapt Announces Positive Results for Multi-Allergen OIT Candidate from Phase 1/2...

FDA Panel Supports Approval of neffy® Epinephrine Nasal Spray

DBV Outlines Path to Regulatory Approval of Viaskin Peanut Patch

Nanoparticle Appears to Prevent, Treat Peanut Allergies in Mice

Hoping Needle-Free Intranasal Epinephrine will be Approved? Tell the FDA!

FDA Schedules Review of neffy®, an Intranasal Alternative to Epinephrine Auto-Injectors

Company Announces First Patient Dosing with Peanut Allergy Vaccine

Your School On Our Map

Put Your School on the Map